| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kamischke A et al. | Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11232016 |
| Godsland IF | Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. | 2001 | Fertil. Steril. | pmid:11334901 |
| Elomaa K et al. | The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives. | 2001 | Contraception | pmid:11257243 |
| Cacciatore B et al. | Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. | 2001 | Am. J. Obstet. Gynecol. | pmid:11303197 |
| Harwood B and Mishell DR | Contraceptive vaginal rings. | 2001 | Semin. Reprod. Med. | pmid:11727180 |
| Aisaka K | [Add back therapy for patients with endometriosis]. | 2001 | Nippon Rinsho | pmid:11235150 |
| Kondoh Y et al. | A longitudinal study of disturbances of the hypothalamic-pituitary-adrenal axis in women with progestin-negative functional hypothalamic amenorrhea. | 2001 | Fertil. Steril. | pmid:11591409 |
| Nordin BE et al. | Bone densitometry in clinical practice: longitudinal measurements at three sites in postmenopausal women on five treatments. | 2001 | Climacteric | pmid:11594313 |
| Campagnoli C et al. | Effect of conjugated estrogens on free IGF-I? | 2001 | Fertil. Steril. | pmid:11570370 |
| Berenson AB et al. | A prospective, controlled study of the effects of hormonal contraception on bone mineral density. | 2001 | Obstet Gynecol | pmid:11576570 |
| Haines CJ et al. | The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris. | 2001 | Atherosclerosis | pmid:11730828 |
| Bruhat M et al. | Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study. | 2001 | Maturitas | pmid:11731187 |
| Hampton RM et al. | Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. | 2001 | Contraception | pmid:11672549 |
| Larrea F et al. | A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha. | 2001 | Endocrinology | pmid:11517155 |
| Skarda J | Detection of estrogenicity by bioassay on the mouse mammary gland in vivo. | 2001 | Physiol Res | pmid:11521738 |
| Rozenberg S et al. | Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms. | 2001 | Int J Gynaecol Obstet | pmid:11226444 |
| Junquera F et al. | A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. | 2001 | Gastroenterology | pmid:11677198 |
| Darko DA et al. | Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy. | 2001 | Diabetes Res. Clin. Pract. | pmid:11689270 |
| Mousa HA and Thong J | Omental pregnancy in a woman taking the progestogen-only pill. | 2001 | Acta Obstet Gynecol Scand | pmid:11846713 |
| Teede HJ et al. | Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women. | 2001 | Clin. Sci. | pmid:11171290 |
| Gravholt CH et al. | Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. | 2001 | Am. J. Physiol. Endocrinol. Metab. | pmid:11158935 |
| Sørensen MB et al. | Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. | 2001 | Obes. Res. | pmid:11595778 |
| Alexandersen P et al. | Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11158042 |
| Endrikat J et al. | Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone. | 2001 | Contraception | pmid:11535206 |
| Herkert O et al. | Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. | 2001 | Circulation | pmid:11733402 |
| Teede HJ et al. | A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. | 2001 | Clin. Endocrinol. (Oxf) | pmid:11894980 |
| Sørensen MB et al. | Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement. | 2001 | Am. J. Obstet. Gynecol. | pmid:11174477 |
| Wihlbäck AC et al. | Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy. | 2001 | Neuroendocrinology | pmid:11408781 |
| Ahmad ME et al. | Evaluation of genotoxic potential of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro. | 2001 | Mutat. Res. | pmid:11423341 |
| Smit J et al. | Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa. | 2001 | BMC Health Serv Res | pmid:11401729 |
| Blom MJ et al. | Metabolism of norethisterone and norethisterone derivatives in rat uterus, vagina, and aorta. | 2001 | Drug Metab. Dispos. | pmid:11408363 |
| Obruca A et al. | Ovarian function during and after treatment with the new progestagen Org 30659. | 2001 | Fertil. Steril. | pmid:11438328 |
| Guzic-Salobir B et al. | Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women. | 2001 | J. Intern. Med. | pmid:11902819 |
| Dören M et al. | Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. | 2001 | Fertil. Steril. | pmid:11239541 |
| Perera M et al. | The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11238498 |
| Bulent Tiras M et al. | Effects of a monthly injectable steroidal contraceptive, Mesigyna, on menstrual pattern, lipoproteins, and coagulation parameters. | 2001 | Contraception | pmid:11368988 |
| Høibraaten E et al. | The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial. | 2001 | Thromb. Haemost. | pmid:11372667 |
| Odmark IS et al. | Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate. | 2001 | Am. J. Obstet. Gynecol. | pmid:11349178 |
| Posaci C et al. | Effects of HRT on serum levels of IGF-I in postmenopausal women. | 2001 | Maturitas | pmid:11684375 |
| Gruschke A and Kuhl H | Validity of radioimmunological methods for determining free testosterone in serum. | 2001 | Fertil. Steril. | pmid:11532484 |
| Van Vliet H et al. | Biphasic versus monophasic oral contraceptives for contraception. | 2001 | Cochrane Database Syst Rev | pmid:11687135 |
| Van Vliet H et al. | Biphasic versus triphasic oral contraceptives for contraception. | 2001 | Cochrane Database Syst Rev | pmid:11687185 |
| Wihlbäck AC et al. | Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding. | 2001 | Obstet Gynecol | pmid:11530128 |
| Boyd RA et al. | Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol. | 2001 | Contraception | pmid:11292470 |
| SendaÄŸ F et al. | Mammographic density changes during different postmenopausal hormone replacement therapies. | 2001 | Fertil. Steril. | pmid:11532462 |
| Høibraaten E et al. | Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial. | 2001 | Br. J. Haematol. | pmid:11703344 |
| Brewer M et al. | Rhesus macaque model for ovarian cancer chemoprevention. | 2001 | Comp. Med. | pmid:11924802 |
| Inglis AM et al. | Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers. | 2001 | J Clin Pharmacol | pmid:11402638 |
| Koch P | Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch. | 2001 | Contact Derm. | pmid:11205390 |
| Speroff L et al. | The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms. | 2000 Nov-Dec | Menopause | pmid:11127760 |
| Saha A et al. | Effects of oral contraceptive norethindrone on blood-lipid and lipid peroxidation parameters. | 2000 Nov-Dec | Acta Pol Pharm | pmid:11243250 |
| Cagnacci A et al. | Transdermal administration of estradiol and norethisterone: effect on the uterus and uterine arteries. | 2000 Mar-Apr | Menopause | pmid:10746894 |
| Gravholt CH et al. | Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone. | 2000 | Atherosclerosis | pmid:10781652 |
| Dören M et al. | Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. | 2000 | Am. J. Obstet. Gynecol. | pmid:10992176 |
| Wu Z et al. | Simultaneous quantitative determination of norgestrel and progesterone in human serum by high-performance liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. | 2000 | Analyst | pmid:11219053 |
| Kamischke A et al. | Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function. | 2000 | Clin. Endocrinol. (Oxf) | pmid:10971453 |
| Schoonen WG et al. | Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives. | 2000 | J. Steroid Biochem. Mol. Biol. | pmid:11162927 |
| Bai J et al. | Regulation of invasive cell behavior by taiman, a Drosophila protein related to AIB1, a steroid receptor coactivator amplified in breast cancer. | 2000 | Cell | pmid:11163181 |
| Symons J et al. | Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators. | 2000 | Obstet Gynecol | pmid:10960627 |
| Li C et al. | Effects of norethisterone acetate addition to estradiol in long term HRT. | 2000 | Maturitas | pmid:11006501 |
| Byrjalsen I et al. | Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium. | 2000 | BJOG | pmid:10740331 |
| Saltevo J et al. | Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy. | 2000 | Diabetes Obes Metab | pmid:11225744 |
| Alexandersen P et al. | Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects. | 2000 | BJOG | pmid:10740332 |
| Kaunitz AM | Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial. | 2000 | Contraception | pmid:10906499 |
| Shakespeare J et al. | Is norethisterone a lifestyle drug? Results of database analysis. | 2000 | BMJ | pmid:10650028 |
| Verhoeven CH et al. | Excretion balance and metabolism of the progestagen Org 30659 in healthy postmenopausal women. | 2000 | J. Steroid Biochem. Mol. Biol. | pmid:10822023 |
| Teede HJ et al. | Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. | 2000 | Arterioscler. Thromb. Vasc. Biol. | pmid:10807761 |
| Winkler UH et al. | Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study. | 2000 | Fertil. Steril. | pmid:10899490 |
| Cooke I et al. | Antifibrinolytics for heavy menstrual bleeding. | 2000 | Cochrane Database Syst Rev | pmid:10796518 |
| Lethaby A et al. | Cyclical progestogens for heavy menstrual bleeding. | 2000 | Cochrane Database Syst Rev | pmid:10796587 |
| Lethaby AE et al. | Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. | 2000 | Cochrane Database Syst Rev | pmid:10796865 |
| Shadle CR et al. | A double-blind, placebo-controlled evaluation of the effect of oral doses of rizatriptan 10 mg on oral contraceptive pharmacokinetics in healthy female volunteers. | 2000 | J Clin Pharmacol | pmid:10709161 |
| Shen Y et al. | Regulation of biodegradability and drug release behavior of aliphatic polyesters by blending. | 2000 | J. Biomed. Mater. Res. | pmid:10756311 |
| Fábián G et al. | An unusual multiplex cause of severe gastrointestinal bleeding in a haemodialysed patient. | 2000 | Nephrol. Dial. Transplant. | pmid:11071980 |
| Lethaby A et al. | Antifibrinolytics for heavy menstrual bleeding. | 2000 | Cochrane Database Syst Rev | pmid:11034679 |
| Gao J et al. | Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells. | 2000 | Mol. Endocrinol. | pmid:11117526 |
| Deckers GH et al. | Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals. | 2000 | J. Steroid Biochem. Mol. Biol. | pmid:11086227 |
| Wonodirekso S et al. | Endometrial epithelial integrity and subepithelial reticular fibre expression in progestin contraceptive acceptors. | 2000 | Hum. Reprod. | pmid:11041235 |
| Bassol S et al. | Mesigyna once-a-month combined injectable contraceptive: experience in Latin America. | 2000 | Contraception | pmid:10906501 |
| von Kesserü E et al. | Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. | 2000 | Contraception | pmid:10906502 |
| Heald A et al. | Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis. | 2000 | Am. J. Obstet. Gynecol. | pmid:10992179 |
| Garceau RJ et al. | Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives. | 2000 | Contraception | pmid:11239615 |
| Grant C et al. | Management of menorrhagia in primary care-impact on referral and hysterectomy: data from the Somerset Morbidity Project. | 2000 | J Epidemiol Community Health | pmid:10942454 |
| Amaro R and Barkin JS | Diagnostic and therapeutic options in obscure gastrointestinal blood loss. | 2000 | Curr Gastroenterol Rep | pmid:10998667 |
| Notelovitz M et al. | Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause. | 2000 | Am. J. Obstet. Gynecol. | pmid:10649149 |
| Kamali P et al. | Cardiovascular responses of perimenopausal women to hormonal replacement therapy. | 2000 | Am. J. Obstet. Gynecol. | pmid:10649151 |
| Kovacs GT et al. | A pre-coital pill? A preliminary in vitro study. | 2000 | Br J Fam Plann | pmid:10920297 |
| Spencer CP et al. | Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. | 2000 | Metab. Clin. Exp. | pmid:10877199 |
| Owens D et al. | Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate. | 2000 | Diabet. Med. | pmid:10821298 |
| Stachenfeld NS et al. | Estrogen modifies the temperature effects of progesterone. | 2000 | J. Appl. Physiol. | pmid:10797125 |
| Bständig B et al. | Effectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up. | 2000 | J. Assist. Reprod. Genet. | pmid:10806591 |
| Sturdee DW et al. | The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. | 2000 | BJOG | pmid:11117768 |
| Ozsener S et al. | The effect of continuous combined oral estradiol and norethisterone on the renal and internal carotid artery pulsatility indices in postmenopausal women. | 2000 | Int J Gynaecol Obstet | pmid:10854874 |
| Perry W and Wiseman RA | Combined oral oestradiol valerate-norethisterone treatment over three years in postmenopausal women: correlation between oestrogen levels and bone mineral density sites. | 2000 | BJOG | pmid:11117769 |
| Kurman RJ et al. | Norethindrone acetate and estradiol-induced endometrial hyperplasia. | 2000 | Obstet Gynecol | pmid:10960628 |
| Halleen JM et al. | Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. | 2000 | J. Bone Miner. Res. | pmid:10893682 |
| Ylikorkala O et al. | Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy. | 2000 | Clin Ther | pmid:10868559 |
| Fraser IS et al. | Vaginal epithelial surface appearances in women using vaginal rings for contraception. | 2000 | Contraception | pmid:10802278 |
| Cromie MA et al. | Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group. | 2000 | Contraception | pmid:10745070 |
| El Bouhmadi A et al. | 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives. | 2000 | Clin. Hemorheol. Microcirc. | pmid:10831061 |